Prostate News Archive
02-Apr-2007
FDA Panel Endorses Vaccine to Treat Prostate Cancer -- If OK'D, Would Be First of New Class of Drug (RedNova)
By Associated Press WASHINGTON - Federal health advisers have endorsed an experimental vaccine to treat advanced prostate cancer as safe and effective. The Food and Drug Administration advisers voted unanimously Thursday to say Provenge is safe. Vaccine Therapy For Prostate Cancer (CBS News)
An estimated 27,000 men in the United States will die of prostate cancer this year. A new vaccine could offer a new way to combat the disease, Dr. Jon LaPook reports. Prostate Cancer: New Genetic Clues (Newsweek)
Scientists say important new genetic findings open up fresh areas of research. Prostate cancer vaccine given nod by FDA panel (Cancerfacts.com)
SEATTLE ? March 30, 2007 /PRNewswire-FirstCall/ ? Dendreon Corporation announced that a key FDA advisory panel has recommended to the FDA that its prostate cancer vaccine PROVENGE (sipuleucel-T) be approved for the treatment of patients with no symptoms of metastatic, androgen-independent (also known as hormone refractory) prostate cancer.
Back to Prostate News Archive
